Table 2 Open in new tab Anthropometric...

	Male	Female	P Two-Way ANOVA
n = 88	21	21	27	19
Age, y	34 ± 10	40 ± 10	44 ± 9	48 ± 13	.026	<.001	.504
Weight, kg	104 ± 22	109 ± 25	90 ± 24	94 ± 9	.337	.003	.831
BMI, kg/m²	32.7 ± 5.6	36.2 ± 7.8	35.4 ± 7.7	36.9 ± 3.4	.076	.239	.485
Body fat, %	33.5 ± 9.4	37.8 ± 7.7	48.5 ± 8.1	48.8 ± 3.9	.171	<.001	.217
Waist circumference, cm	108 ± 16	116 ± 17	102 ± 20	110 ± 7	.026	.102	.963
WHR	0.95 ± 0.07	1.01 ± 0.08	0.86 ± 0.10	0.95 ± 0.06	<.001	<.001	.450
PAL, AU	1.39 ± 0.40	1.40 ± 0.55	1.68 ± 0.35	1.65 ± 0.47	.970	.144	.907
SBP, mm Hg	123 ± 14	124 ± 17	119 ± 17	131 ± 17	.066	.657	.139
DBP, mm Hg	77 ± 10	79 ± 10	76 ± 10	82 ± 11	.043	.504	.271
Glucose, mg/dL	90 ± 7	103 ± 15	86 ± 11	107 ± 13	<.001	.997	.181
Insulin, μU/mL	9.6 ± 5.5	17.9 ± 10.6	7.7 ± 5.9	23.8 ± 19.5	<.001	.416	.111
Glucose 2-h OGTT, mg/dL	105 ± 20	159 ± 56	113 ± 29	172 ± 62	<.001	.268	.814
Insulin 2-h OGTT, μU/mL	70.2 ± 55.8	106.8 ± 55.5	61.4 ± 52.5	130.3 ± 69.2	<.001	.559	.198
HOMA	2.15 ± 1.28	4.67 ± 3.12	1.70 ± 1.41	6.59 ± 6.40	<.001	.325	.118
QUICKI	0.352 ± 0.035	0.317 ± 0.031^a	0.375 ± 0.049	0.303 ± 0.023^b	<.001	.585	.022
Triglycerides, mg/dL	52 (50–58)	415 (335–496)^b	40 (37–57)	298 (283–350)^b	<.001	<.001	.002
Total cholesterol, mg/dL	166 ± 36	250 ± 49	186 ± 34	249 ± 41	<.001	.268	.223
LDL-C, mg/dL	105 ± 35	154 ± 47	109 ± 31	143 ± 39	<.001	.669	.430
HDL-C, mg/dL	50 ± 12	38 ± 6^a	68 ± 15	44 ± 11^b	<.001	<.001	.024
nonHDL-C, mg/dL	116 ± 36	213 ± 47	118 ± 30	206 ± 38	<.001	.761	.564
Uric acid, mg/dL	6.1 ± 0.7	7.1 ± 1.6	4.4 ± 1.1	6.0 ± 1.3	<.001	<.001	.279
Creatinine, mg/dL	0.95 ± 0.13	0.89 ± 0.13	0.70 ± 0.10	0.78 ± 0.11^c	.743	<.001	.004
WBC, 10⁶ cells/mL	6.0 ± 1.3	7.0 ± 1.5	6.0 ± 1.7	7.6 ± 1.6	<.001	.324	.359
ALT, IU/L	35 ± 24	37 ± 22	19 ± 18	30 ± 19	.124	.015	.352
AST, IU/L	18 ± 8	22 ± 10	16 ± 15	18 ± 8	.241	.219	.655
AST to ALT ratio	0.60 ± 0.24	0.63 ± 0.12	0.97 ± 0.36	0.66 ± 0.18^b	.011	<.001	.004
γ-GT, IU/L	24 ± 21	48 ± 32	13 ± 8	37 ± 32	<.001	.039	.946
Leptin, ng/mL	17.4 ± 13.3	21.9 ± 21.2	40.7 ± 23.5	45.1 ± 18.8	.301	<.001	.994

Male

Female

P Two-Way ANOVA

Low TG

High TG

Low TG

High TG

Gender

Interquartile Range

n = 88

Age, y

34 ± 10

40 ± 10

44 ± 9

48 ± 13

.026

<.001

.504

Weight, kg

104 ± 22

109 ± 25

90 ± 24

94 ± 9

.337

.003

.831

BMI, kg/m²

32.7 ± 5.6

36.2 ± 7.8

35.4 ± 7.7

36.9 ± 3.4

.076

.239

.485

Body fat, %

33.5 ± 9.4

37.8 ± 7.7

48.5 ± 8.1

48.8 ± 3.9

.171

<.001

.217

Waist circumference, cm

108 ± 16

116 ± 17

102 ± 20

110 ± 7

.026

.102

.963

WHR

0.95 ± 0.07

1.01 ± 0.08

0.86 ± 0.10

0.95 ± 0.06

<.001

.450

PAL, AU

1.39 ± 0.40

1.40 ± 0.55

1.68 ± 0.35

1.65 ± 0.47

.970

.144

.907

SBP, mm Hg

123 ± 14

124 ± 17

119 ± 17

131 ± 17

.066

.657

.139

DBP, mm Hg

77 ± 10

79 ± 10

76 ± 10

82 ± 11

.043

.504

.271

Glucose, mg/dL

90 ± 7

103 ± 15

86 ± 11

107 ± 13

<.001

.997

.181

Insulin, μU/mL

9.6 ± 5.5

17.9 ± 10.6

7.7 ± 5.9

23.8 ± 19.5

<.001

.416

.111

Glucose 2-h OGTT, mg/dL

105 ± 20

159 ± 56

113 ± 29

172 ± 62

<.001

.268

.814

Insulin 2-h OGTT, μU/mL

70.2 ± 55.8

106.8 ± 55.5

61.4 ± 52.5

130.3 ± 69.2

<.001

.559

.198

HOMA

2.15 ± 1.28

4.67 ± 3.12

1.70 ± 1.41

6.59 ± 6.40

<.001

.325

.118

QUICKI

0.352 ± 0.035

0.317 ± 0.031^a

0.375 ± 0.049

0.303 ± 0.023^b

<.001

.585

.022

Triglycerides, mg/dL

52 (50–58)

415 (335–496)^b

40 (37–57)

298 (283–350)^b

<.001

.002

Total cholesterol, mg/dL

166 ± 36

250 ± 49

186 ± 34

249 ± 41

<.001

.268

.223

LDL-C, mg/dL

105 ± 35

154 ± 47

109 ± 31

143 ± 39

<.001

.669

.430

HDL-C, mg/dL

50 ± 12

38 ± 6^a

68 ± 15

44 ± 11^b

<.001

.024

nonHDL-C, mg/dL

116 ± 36

213 ± 47

118 ± 30

206 ± 38

<.001

.761

.564

Uric acid, mg/dL

6.1 ± 0.7

7.1 ± 1.6

4.4 ± 1.1

6.0 ± 1.3

<.001

.279

Creatinine, mg/dL

0.95 ± 0.13

0.89 ± 0.13

0.70 ± 0.10

0.78 ± 0.11^c

.743

<.001

.004

WBC, 10⁶ cells/mL

6.0 ± 1.3

7.0 ± 1.5

6.0 ± 1.7

7.6 ± 1.6

<.001

.324

.359

ALT, IU/L

35 ± 24

37 ± 22

19 ± 18

30 ± 19

.124

.015

.352

AST, IU/L

18 ± 8

22 ± 10

16 ± 15

18 ± 8

.241

.219

.655

AST to ALT ratio

0.60 ± 0.24

0.63 ± 0.12

0.97 ± 0.36

0.66 ± 0.18^b

.011

<.001

.004

γ-GT, IU/L

24 ± 21

48 ± 32

13 ± 8

37 ± 32

<.001

.039

.946

Leptin, ng/mL

17.4 ± 13.3

21.9 ± 21.2

40.7 ± 23.5

45.1 ± 18.8

.301

<.001

.994

	Male	Female	P Two-Way ANOVA
n = 88	21	21	27	19
Age, y	34 ± 10	40 ± 10	44 ± 9	48 ± 13	.026	<.001	.504
Weight, kg	104 ± 22	109 ± 25	90 ± 24	94 ± 9	.337	.003	.831
BMI, kg/m²	32.7 ± 5.6	36.2 ± 7.8	35.4 ± 7.7	36.9 ± 3.4	.076	.239	.485
Body fat, %	33.5 ± 9.4	37.8 ± 7.7	48.5 ± 8.1	48.8 ± 3.9	.171	<.001	.217
Waist circumference, cm	108 ± 16	116 ± 17	102 ± 20	110 ± 7	.026	.102	.963
WHR	0.95 ± 0.07	1.01 ± 0.08	0.86 ± 0.10	0.95 ± 0.06	<.001	<.001	.450
PAL, AU	1.39 ± 0.40	1.40 ± 0.55	1.68 ± 0.35	1.65 ± 0.47	.970	.144	.907
SBP, mm Hg	123 ± 14	124 ± 17	119 ± 17	131 ± 17	.066	.657	.139
DBP, mm Hg	77 ± 10	79 ± 10	76 ± 10	82 ± 11	.043	.504	.271
Glucose, mg/dL	90 ± 7	103 ± 15	86 ± 11	107 ± 13	<.001	.997	.181
Insulin, μU/mL	9.6 ± 5.5	17.9 ± 10.6	7.7 ± 5.9	23.8 ± 19.5	<.001	.416	.111
Glucose 2-h OGTT, mg/dL	105 ± 20	159 ± 56	113 ± 29	172 ± 62	<.001	.268	.814
Insulin 2-h OGTT, μU/mL	70.2 ± 55.8	106.8 ± 55.5	61.4 ± 52.5	130.3 ± 69.2	<.001	.559	.198
HOMA	2.15 ± 1.28	4.67 ± 3.12	1.70 ± 1.41	6.59 ± 6.40	<.001	.325	.118
QUICKI	0.352 ± 0.035	0.317 ± 0.031^a	0.375 ± 0.049	0.303 ± 0.023^b	<.001	.585	.022
Triglycerides, mg/dL	52 (50–58)	415 (335–496)^b	40 (37–57)	298 (283–350)^b	<.001	<.001	.002
Total cholesterol, mg/dL	166 ± 36	250 ± 49	186 ± 34	249 ± 41	<.001	.268	.223
LDL-C, mg/dL	105 ± 35	154 ± 47	109 ± 31	143 ± 39	<.001	.669	.430
HDL-C, mg/dL	50 ± 12	38 ± 6^a	68 ± 15	44 ± 11^b	<.001	<.001	.024
nonHDL-C, mg/dL	116 ± 36	213 ± 47	118 ± 30	206 ± 38	<.001	.761	.564
Uric acid, mg/dL	6.1 ± 0.7	7.1 ± 1.6	4.4 ± 1.1	6.0 ± 1.3	<.001	<.001	.279
Creatinine, mg/dL	0.95 ± 0.13	0.89 ± 0.13	0.70 ± 0.10	0.78 ± 0.11^c	.743	<.001	.004
WBC, 10⁶ cells/mL	6.0 ± 1.3	7.0 ± 1.5	6.0 ± 1.7	7.6 ± 1.6	<.001	.324	.359
ALT, IU/L	35 ± 24	37 ± 22	19 ± 18	30 ± 19	.124	.015	.352
AST, IU/L	18 ± 8	22 ± 10	16 ± 15	18 ± 8	.241	.219	.655
AST to ALT ratio	0.60 ± 0.24	0.63 ± 0.12	0.97 ± 0.36	0.66 ± 0.18^b	.011	<.001	.004
γ-GT, IU/L	24 ± 21	48 ± 32	13 ± 8	37 ± 32	<.001	.039	.946
Leptin, ng/mL	17.4 ± 13.3	21.9 ± 21.2	40.7 ± 23.5	45.1 ± 18.8	.301	<.001	.994

Table 2

Open in new tab

Anthropometric and Biochemical Characteristics of the Subjects Included in the Study of Dyslipidemia According to Low or High Triglyceride Concentrations

	Male		Female		P Two-Way ANOVA
	Low TG	High TG	Low TG	High TG	TG	Gender	Interquartile Range
n = 88	21	21	27	19
Age, y	34 ± 10	40 ± 10	44 ± 9	48 ± 13	.026	<.001	.504
Weight, kg	104 ± 22	109 ± 25	90 ± 24	94 ± 9	.337	.003	.831
BMI, kg/m²	32.7 ± 5.6	36.2 ± 7.8	35.4 ± 7.7	36.9 ± 3.4	.076	.239	.485
Body fat, %	33.5 ± 9.4	37.8 ± 7.7	48.5 ± 8.1	48.8 ± 3.9	.171	<.001	.217
Waist circumference, cm	108 ± 16	116 ± 17	102 ± 20	110 ± 7	.026	.102	.963
WHR	0.95 ± 0.07	1.01 ± 0.08	0.86 ± 0.10	0.95 ± 0.06	<.001	<.001	.450
PAL, AU	1.39 ± 0.40	1.40 ± 0.55	1.68 ± 0.35	1.65 ± 0.47	.970	.144	.907
SBP, mm Hg	123 ± 14	124 ± 17	119 ± 17	131 ± 17	.066	.657	.139
DBP, mm Hg	77 ± 10	79 ± 10	76 ± 10	82 ± 11	.043	.504	.271
Glucose, mg/dL	90 ± 7	103 ± 15	86 ± 11	107 ± 13	<.001	.997	.181
Insulin, μU/mL	9.6 ± 5.5	17.9 ± 10.6	7.7 ± 5.9	23.8 ± 19.5	<.001	.416	.111
Glucose 2-h OGTT, mg/dL	105 ± 20	159 ± 56	113 ± 29	172 ± 62	<.001	.268	.814
Insulin 2-h OGTT, μU/mL	70.2 ± 55.8	106.8 ± 55.5	61.4 ± 52.5	130.3 ± 69.2	<.001	.559	.198
HOMA	2.15 ± 1.28	4.67 ± 3.12	1.70 ± 1.41	6.59 ± 6.40	<.001	.325	.118
QUICKI	0.352 ± 0.035	0.317 ± 0.031^a	0.375 ± 0.049	0.303 ± 0.023^b	<.001	.585	.022
Triglycerides, mg/dL	52 (50–58)	415 (335–496)^b	40 (37–57)	298 (283–350)^b	<.001	<.001	.002
Total cholesterol, mg/dL	166 ± 36	250 ± 49	186 ± 34	249 ± 41	<.001	.268	.223
LDL-C, mg/dL	105 ± 35	154 ± 47	109 ± 31	143 ± 39	<.001	.669	.430
HDL-C, mg/dL	50 ± 12	38 ± 6^a	68 ± 15	44 ± 11^b	<.001	<.001	.024
nonHDL-C, mg/dL	116 ± 36	213 ± 47	118 ± 30	206 ± 38	<.001	.761	.564
Uric acid, mg/dL	6.1 ± 0.7	7.1 ± 1.6	4.4 ± 1.1	6.0 ± 1.3	<.001	<.001	.279
Creatinine, mg/dL	0.95 ± 0.13	0.89 ± 0.13	0.70 ± 0.10	0.78 ± 0.11^c	.743	<.001	.004
WBC, 10⁶ cells/mL	6.0 ± 1.3	7.0 ± 1.5	6.0 ± 1.7	7.6 ± 1.6	<.001	.324	.359
ALT, IU/L	35 ± 24	37 ± 22	19 ± 18	30 ± 19	.124	.015	.352
AST, IU/L	18 ± 8	22 ± 10	16 ± 15	18 ± 8	.241	.219	.655
AST to ALT ratio	0.60 ± 0.24	0.63 ± 0.12	0.97 ± 0.36	0.66 ± 0.18^b	.011	<.001	.004
γ-GT, IU/L	24 ± 21	48 ± 32	13 ± 8	37 ± 32	<.001	.039	.946
Leptin, ng/mL	17.4 ± 13.3	21.9 ± 21.2	40.7 ± 23.5	45.1 ± 18.8	.301	<.001	.994

	Male		Female		P Two-Way ANOVA
	Low TG	High TG	Low TG	High TG	TG	Gender	Interquartile Range
n = 88	21	21	27	19
Age, y	34 ± 10	40 ± 10	44 ± 9	48 ± 13	.026	<.001	.504
Weight, kg	104 ± 22	109 ± 25	90 ± 24	94 ± 9	.337	.003	.831
BMI, kg/m²	32.7 ± 5.6	36.2 ± 7.8	35.4 ± 7.7	36.9 ± 3.4	.076	.239	.485
Body fat, %	33.5 ± 9.4	37.8 ± 7.7	48.5 ± 8.1	48.8 ± 3.9	.171	<.001	.217
Waist circumference, cm	108 ± 16	116 ± 17	102 ± 20	110 ± 7	.026	.102	.963
WHR	0.95 ± 0.07	1.01 ± 0.08	0.86 ± 0.10	0.95 ± 0.06	<.001	<.001	.450
PAL, AU	1.39 ± 0.40	1.40 ± 0.55	1.68 ± 0.35	1.65 ± 0.47	.970	.144	.907
SBP, mm Hg	123 ± 14	124 ± 17	119 ± 17	131 ± 17	.066	.657	.139
DBP, mm Hg	77 ± 10	79 ± 10	76 ± 10	82 ± 11	.043	.504	.271
Glucose, mg/dL	90 ± 7	103 ± 15	86 ± 11	107 ± 13	<.001	.997	.181
Insulin, μU/mL	9.6 ± 5.5	17.9 ± 10.6	7.7 ± 5.9	23.8 ± 19.5	<.001	.416	.111
Glucose 2-h OGTT, mg/dL	105 ± 20	159 ± 56	113 ± 29	172 ± 62	<.001	.268	.814
Insulin 2-h OGTT, μU/mL	70.2 ± 55.8	106.8 ± 55.5	61.4 ± 52.5	130.3 ± 69.2	<.001	.559	.198
HOMA	2.15 ± 1.28	4.67 ± 3.12	1.70 ± 1.41	6.59 ± 6.40	<.001	.325	.118
QUICKI	0.352 ± 0.035	0.317 ± 0.031^a	0.375 ± 0.049	0.303 ± 0.023^b	<.001	.585	.022
Triglycerides, mg/dL	52 (50–58)	415 (335–496)^b	40 (37–57)	298 (283–350)^b	<.001	<.001	.002
Total cholesterol, mg/dL	166 ± 36	250 ± 49	186 ± 34	249 ± 41	<.001	.268	.223
LDL-C, mg/dL	105 ± 35	154 ± 47	109 ± 31	143 ± 39	<.001	.669	.430
HDL-C, mg/dL	50 ± 12	38 ± 6^a	68 ± 15	44 ± 11^b	<.001	<.001	.024
nonHDL-C, mg/dL	116 ± 36	213 ± 47	118 ± 30	206 ± 38	<.001	.761	.564
Uric acid, mg/dL	6.1 ± 0.7	7.1 ± 1.6	4.4 ± 1.1	6.0 ± 1.3	<.001	<.001	.279
Creatinine, mg/dL	0.95 ± 0.13	0.89 ± 0.13	0.70 ± 0.10	0.78 ± 0.11^c	.743	<.001	.004
WBC, 10⁶ cells/mL	6.0 ± 1.3	7.0 ± 1.5	6.0 ± 1.7	7.6 ± 1.6	<.001	.324	.359
ALT, IU/L	35 ± 24	37 ± 22	19 ± 18	30 ± 19	.124	.015	.352
AST, IU/L	18 ± 8	22 ± 10	16 ± 15	18 ± 8	.241	.219	.655
AST to ALT ratio	0.60 ± 0.24	0.63 ± 0.12	0.97 ± 0.36	0.66 ± 0.18^b	.011	<.001	.004
γ-GT, IU/L	24 ± 21	48 ± 32	13 ± 8	37 ± 32	<.001	.039	.946
Leptin, ng/mL	17.4 ± 13.3	21.9 ± 21.2	40.7 ± 23.5	45.1 ± 18.8	.301	<.001	.994

Abbreviations: BF%, body fat percentage; DBP, diastolic blood pressure; SBP, systolic blood pressure. Data are mean ± SD or median (interquartile range). Differences between groups were analyzed by a two-way ANOVA. If an interaction was detected, a one-way ANOVA followed by Fisher’s LSD tests was performed. Bold values denote statistical significance at P < .05.

P < .01 vs low TG of the same gender.

P < .001 vs low TG of the same gender.

P < .05 vs low TG of the same gender.

This Feature Is Available To Subscribers Only